Ordenar

Buscar

01/10/2024 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry
Estrada, P, Domínguez-Alvaro, M, Melero-González, RB, de Miguel, E, Silva-Díaz, M, Valero, JA, González, I, Sánchez-Martín, J, Narváez, J, Galíndez, E, Mendizábal, J, Iñiguez-Ubiaga, CL, Rodríguez-Rodríguez, L, Loricera, J, Muñoz, A, Moya-Alvarado, P, Moran-alvarez, P, Navarro-angeles, VA, Galisteo, C, Castañeda, S, Blanco, R. 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry. Journal of Clinical Medicine. 2024; 13(20)DOI:10.3390/jcm13206215. PMID:39458165. IF:2.900(Q1/2D).
01/10/2024 Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis.
Álvaro-Gracia Álvaro JM, Díaz Del Campo Fontecha P, Andréu Sánchez JL, Balsa Criado A, Cáliz Cáliz R, Castrejón Fernández I, Corominas H, Gómez Puerta JA, Manrique Arija S, Mena Vázquez N, Ortiz García A, Plasencia Rodríguez C, Silva Fernández L, Tornero Molina J. Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis.. Reumatologia Clinica. 2024; 20(8)DOI:10.1016/j.reumae.2024.09.002. PMID:39341701. IF:(Q/D).
01/10/2024 Parasympathetic nervous system: A key role in control and mood disorders in patients with asthma
Soto-Retes, L, Milagro, J, Crespo-Lessmann, A, Curto, E, Medina, EFM, Bailon, R, Gil, E, Laguna, P, Plaza, V. Parasympathetic nervous system: A key role in control and mood disorders in patients with asthma. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 2024; 133(4)DOI:10.1016/j.anai.2024.07.022. PMID:39074657. IF:4.700(Q1/1D).
01/10/2024 Prediction of COVID-19 severity using machine learning
Karaduzovic-Hadziabdic, K, Adilovic, M, Zhang, L, Lumley, A, Shah, PA, Shoaib, M, Satagopam, V, Srivastava, PK, Emanueli, C, Greco, S, Made, A, Padro, T, Domingo, P, Lustrek, M, Scholz, M, Rosolowski, M, Jordan, M, Benczik, B, Agg, B, Ferdinandy, P, Baker, AH, Fagherazzi, G, Ollert, M, Michel, J, Sanchez, G, Firat, H, Brandenburger, T, Martelli, F, Badimon, L, Devaux, Y. Prediction of COVID-19 severity using machine learning. Clinical and Translational Medicine. 2024; 14(10)DOI:10.1002/ctm2.70042. PMID:39370709. IF:6.800(Q1/2D).
01/10/2024 The proteome of circulating exosomes in appropriate- versus small-for-gestational-age infants: differentially expressed proteins at birth associate with measures of weight gain, liver fat, insulin resistance and adrenarche at age 7
Díaz, M, Quesada, T, Villarroya, F, López-Bermejo, A, Casano, P, De Zegher, F, Ibanez, L. The proteome of circulating exosomes in appropriate- versus small-for-gestational-age infants: differentially expressed proteins at birth associate with measures of weight gain, liver fat, insulin resistance and adrenarche at age 7. Hormone Research in Paediatrics. 2024; 97DOI:. PMID:. IF:2.700(Q1/2D).
01/10/2024 Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study
Bellmunt, J, Maroto, P, Bonfill, T, Vazquez, F, Perez-Gracia, JL, Juanpere, N, Hernandez-Prat, A, Hernandez-Llodra, S, Rovira, A, Juan, OS, Rodriguez-Vida, A. Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study. Clinical Genitourinary Cancer. 2024; 22(5)DOI:10.1016/j.clgc.2024.102123. PMID:38905731. IF:2.700(Q2/3D).
01/10/2024 The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review
Abu Remilah, A, Krayim, B, Amir, E, Tibau, A, Robson, ME, Abuhadra, N, Chen, Y, Shepshelovich, D, Goldvaser, H. The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2024; 202DOI:10.1016/j.critrevonc.2024.104455. PMID:39067779. IF:5.600(Q1/2D).
01/10/2024 Prognostic Laboratory Parameters in Imfirst: Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
de Castro, J, Dols, MC, Gómez, MD, Vega, AM, Aix, SP, Arriola, E, Carcereny, E, Majem, M, Vence, GH, González, EE, Pradera, JF, Granados, ALO, Morales, MG, Sureda, BM, Núñez, NF, Provencio, M, González-Mancha, N, Fajardo, CA, Lerones, N, Campelo, RG. Prognostic Laboratory Parameters in Imfirst: Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).